In the Media

2017

 
Jun. 1, 2017
  MassDevice
   
Apr. 3, 2017 Rapid Diagnosis of Invasive Candidiasis
  Clinical Lab Products
   
Mar. 8, 2017

Test May Yield More Accurate Antifungal Therapy

  Pharmacy Practice News
   
Feb. 17, 2017

New data shows use of T2 Biosystem’s diagnostic panel for rapid detection of sepsis, caused by Candida, could save hospitals millions of dollars annually

  Becker's Hospital Review
   
Feb. 10, 2017 T2MR Technology and its Ability to Offer new Insights into Hemostasis
  Genomeweb
   
Nov. 12, 2016 At AMP Meeting, T2 Reports Annual Cost Saving of Up to $3M for Hospital Using Rapid Sepsis MDx
  Genomeweb
   

2016

 
Sep. 28, 2016 7 Medtech Discovery of the Decade Nominees—T2Candida Panel
  Medical Device and Diagnostic Industry
   
Aug. 31, 2016 Taking Aim at Sepsis
  Clinical Lab Products
   
Aug. 23, 2016 The Ultimate Battle Against MRSA
  Diagnostic Testing and Emerging Technology
   
Aug. 12, 2016 Novel MR-Based Test Shortens Sepsis Detection Time
  AuntMinnie
   
Jul. 28, 2016 Emerging Methodology: A Game-Changer in the Always-Urgent Detection of Sepsis
  Advance for the Laboratory
   
Jun. 26, 2016 Fastest-Growing Public Companies in Massachusetts
  Boston Business Journal
   
Jun. 21, 2016 50 Smartest Companies 2016
  MIT Technology Review
   
Jun. 14, 2016 Superbug Hearing: Will Congress Pick Up Ali's Fight Against Sepsis?
  Forbes
   
Jun. 3, 2016 Study Shows MRI Technology Faster At Diagnosing Sepsis
  Medical Device and Diagnostic Industry 
   
May 31, 2016 John McDonough Recognized as One of the Top 10 Most Creative People in Business
  Fast Company
   
Mar. 25, 2016 Executive Profile: Building a Billion-Dollar Business to Take on Health Care’s Biggest Killer 
  Boston Business Journal
   
Mar. 2016 A Blood Scan for Sepsis?
  The Clinical Chemist
   
Feb. 16, 2016 T2 Biosystems Hopes to Gain Market Share with Sepsis Detection Technologies
  Medical Device Daily
   
Jan. 2016 T2Bacteria Panel study results, 1/16
  Cap Today

2015

 
Dec. 1, 2015 T2 Biosystems Has Strong Diagnostic Tool in Fight Against Sepsis
  G2 Intelligence
   
Dec. 1, 2015 Panel Demonstrates Detection of Six Clinically Relevant Bacteria Species Directly from Whole Blood
  Clinical Laboratories
   
Nov. 12, 2015 Can A New Test Help Hospitals Fight Sepsis?
  KQED Science
   
Nov. 12, 2015 Lexington Firm’s New Sepsis Test Places it Among Life Sciences Giants
  Boston Business Journal
   
Nov. 6, 2015 New Machine Cuts Sepsis Diagnosis to Just Five Hours
  Wired UK
   
Nov. 4, 2015 New Sepsis Detector Shrinks the Diagnosis from Days to Hours
  MIT Technology Review
   
Oct. 29, 2015 T2 Biosystems' T2Candida Panel Named Best Medical Technology Product at Prix Galien USA Awards
  GlobeNewswire
   
Aug. 19, 2015 T2 Biosystems Shifts Paradigm for Rapid Pathogen Identification Directly From Sample
  Diagnostic Testing & Emerging Technologies
   
Jul. 9, 2015 New Diagnostic Detects Sepsis in Three Hours
  Bioscience Technology
   
Jul. 7, 2015 Sepsis Diagnostics: The Role of Laboratory Testing in Identifying Sepsis and MDROs
  Advance for Laboratory
   
Jun. 16, 2015 Diagnostic Panel Improves Detection of Candida Infections vs. Blood Cultures (Investigational Study)
  Healio Infectious Disease in Children
   
Jun. 2, 2015 Data From Investigational Study Demonstrates T2Candida® Panel Provides Accurate and Fast Diagnosis of Candida, a Leading Cause of Sepsis, With Only 2mL of Blood From Pediatric Patients
  GlobeNewswire
   
Apr. 17, 2015 Critical Stressors in the Microbiology Lab: Four Cs
  CAP Today
   
Apr. 13. 2015 New Study Describes Economic Consequences of Using T2Candida Panel for Detection of Candidemia
  News Medical
   
Apr. 8, 2015 Study Published in Future Microbiology Demonstrates Significant Cost and Survival Benefits for T2 Biosystems' T2Candida Panel for Sepsis
  GlobeNewswire
   
Apr. 8, 2015 Total Annual Hospital Costs Could be Reduced by Rapid Candidemia Identification
  Medical Xpres
   
Feb. 20, 2015 With MRI Platform, Mass. Firm Aims To Upend Sepsis Diagnosis
  Medical Device & Diagnostic Industry
   
Jan. 16, 2015 T2 Biosystems Candida Sepsis Test Proves Value in Clinical Study
  GenomeWeb Daily News
   

2014

 
   
Dec. 22, 2014 Diagnostic Testing for Fungal Infections 
  Advance Healthcare Network
   
Sept. 24, 2014 T2 Biosystems Jumps on FDA Nod for Sepsis Tests
  MASSDEVICE
   
Sept. 24, 2014 T2 Biosystems Gains Clearance from FDA for Platform to Detect Sepsis
  Medical Device Daily
   
Sept. 24, 2014 US FDA Grants Marketing Authorization to T2 Biosystems' T2Candida & T2Dx for Detection of Sepsis-Causing Pathogens
  Pharmabiz.com
   
Sept. 24, 2014 T2 Biosystems' Sepsis Tests Receive Clearance from FDA
  Bio SmartBrief
   
Sept. 23, 2014 Blood Test for Yeast Infections Approved
  HealthDay
   
Sept. 23, 2014 T2 Biosystems Shares Spike on U.S. Approval for Faster Sepsis Test
  Boston Business Journal
   
Sept. 23, 2014 New Test for Candida Blood Stream Infection Offers Faster Results
  EMPR
   
Sept. 23, 2014 T2 Biosystems Wins FDA Approval for Sepsis Diagnostic System
  FierceMedicalDevices
   
Sept. 23, 2014 FDA Approves First Direct Blood Test for Detection of Yeast Pathogens
  HNGN
   
Sept. 23, 2014 FDA Clears Rapid Blood Test for Sepsis-Causing Pathogens
  Medscape
   
Sept. 23, 2014 FDA Clears New Rapid Test for Candida Infections of Bloodstream
  RTTNews
   
Sept. 23, 2014 With FDA Nod, T2 Bio's Sepsis Test Heads to Commercial Proving Ground
  Xconomy
   
Sept. 23, 2014 T2 Gains on Approval of Fungal Tests
  BioCentury Extra
   
Sept. 23, 2014 FDA Clears T2 Bio Test, System for Identification of Yeast Pathogens
  GenomeWeb Daily News
   
Sept. 22, 2014 FDA Allows Marketing of First Test for Yeast Pathogens
  FDA.gov
   
Sept. 22, 2014 T2 Biosystems Gains FDA Signoff for Time-Saving Candida Dx
  FierceDiagnostics
   
Sept. 22, 2014 T2 Biosystems Receives FDA Authorization to Market T2Candida and T2Dx for Detection of Sepsis-Causing Pathogens
  Reuters
   
Sept. 1, 2014 FDA Green Lights Yeast Pathogen Detecting Blood Test
  FDA News
   
Aug. 8, 2014 T2 Prices Its IPO Shares at $11 Each
  The Boston Globe
   
Aug. 7, 2014 T2 Biosystems Prices 5.2 Shares in IPO at $11 Per Share
  Private Equity & Venture Capital Dow Jones
   
Aug. 6, 2014 T2 Biosystems Slated To Go Public this Week in Increasingly Uncertain Market
  Boston Business Journal
   
Jul. 2, 2014 T2 Biosystems, Bullish on New Candida Dx, Files IPO Plans
  FierceDiagnostics
   
Jun. 4, 2014 T2 Biosystems Files for U.S. Approval of Fast-acting Sepsis Test
  Boston Business Journal
   
Jun. 3, 2014 T2 Biosystems Files for FDA Clearance for Dx System Candida Assay
  Genomeweb
   
Apr. 10, 2014

T2 Biosystems Presents New Data at the Thrombosis and Hemostasis Summit of North America Demonstrating Ability of T2MR Platform Technology to Measure Platelet Activity and Additional Hemostasis Parameters

  BusinessWire
   

2013

 
   
Sept. 9, 2013 T2 Jumps into Pivotal Trial for Candida Assay
  FierceDiagnostics
   
Jul. 22, 2013 T2 Biosystems Aims to Revolutionize Diagnostics
  MassDevice
   
Apr. 24, 2013 Blood Test may Catch Deadly Fungal Infection Quickly
  HealthDay
   
Jan. 8, 2013 JPM: T2 Readies Pivotal Trial for Candida Assay
  FierceMedicalDevices
   

2012

 
   
Nov. 14, 2012 T2 Biosystems Gets Two More Patents for Assay
  MassHighTech
   
Oct. 2, 2012 T2 Biosystems – 2012 Fierce 15
  FierceMedicalDevices
   
Feb. 2, 2012 T2 Biosystems Wins Broad Patent for NMR-based Diagnostics
  MassHighTech
   
Jan. 20, 2012 T2 Biosystems Preps Clinical Trial for Candida Test in Anticipation of FDA Submission
  GenomeWeb
   

2011

 
   
Aug. 22, 2011 Nano-NMR for Diagnostics
  BioCentury on BioBusiness
   
Aug. 10, 2011 T2 Biosystems Closes $23M More for Fast, Cheap Diagnostic Tools
  Xconomy
   
May 17, 2011 MIT Spinoff, T2 Biosystems, Hopes to Slash Deadly Hospital Infection Deaths
  Forbes
   
Apr. 15, 2011 New Test Spots Infections in Hours, Rather than Days
  MIT Technology Review